Betaband event-related desynchronization prior to simple lower limb movement and simulated gait initiation in Parkinson’s disease patient: Magnetoencephalography study

2018 ◽  
Vol 46 ◽  
pp. e77
Author(s):  
J.Y. Yun ◽  
B. Jeon
2020 ◽  
Vol 131 (3) ◽  
pp. 694-702 ◽  
Author(s):  
Arun Singh ◽  
Rachel C. Cole ◽  
Arturo I. Espinoza ◽  
Darin Brown ◽  
James F. Cavanagh ◽  
...  

2019 ◽  
Vol 10 ◽  
Author(s):  
Jonathan H. Drucker ◽  
K. Sathian ◽  
Bruce Crosson ◽  
Venkatagiri Krishnamurthy ◽  
Keith M. McGregor ◽  
...  

2019 ◽  
Author(s):  
Arun Singh ◽  
Rachel C. Cole ◽  
Arturo I. Espinoza ◽  
Darin Brown ◽  
James F. Cavanagh ◽  
...  

ABSTRACTBackgroundMotor and cognitive dysfunction has been linked in patients with Parkinson’s disease (PD). EEG theta and beta rhythms are reliably associated with cognitive and motor functions, respectively. We tested the hypothesis that PD patients with lower-limb abnormalities would exhibit abnormal beta and theta rhythms in the mid-frontal region during action initiation.MethodsWe recruited thirty-nine subjects, including PD patients with FOG (PDFOG+; n=13) and without FOG (PDFOG−; n=13), and demographically-matched healthy subjects (n=13). Scalp electroencephalogram (EEG) signals were collected during a lower-limb pedaling motor task, which required intentional initiation and stopping of a motor movement.ResultsFOG scores were correlated with disease severity and cognition. PDFOG+ patients pedaled with reduced speed and decreased acceleration compared to PDFOG− patients and to controls. PDFOG+ patients exhibited attenuated theta-band (4-8 Hz) power and increased beta-band (13-30 Hz) power at mid-frontal electrode Cz during pedaling. Frontal theta- and beta-band oscillations also correlated with lower-limb movement in PD patients.ConclusionsFrontal theta and beta oscillations are predictors of lower-limb motor symptoms in PD. These data provide insight into the mechanism of lower-limb dysfunction in PD, and could be used to design neuromodulation for PD-related lower-limb abnormalities.


2015 ◽  
Vol 21 (12) ◽  
pp. 1476-1478 ◽  
Author(s):  
Claudio Liguori ◽  
Fabio Placidi ◽  
Alessandro Stefani ◽  
Nicola Biagio Mercuri ◽  
Maria Grazia Marciani ◽  
...  

2021 ◽  
pp. 1-9
Author(s):  
Laura P. Hughes ◽  
Marilia M.M. Pereira ◽  
Deborah A. Hammond ◽  
John B. Kwok ◽  
Glenda M. Halliday ◽  
...  

Background: Reduced activity of lysosomal glucocerebrosidase is found in brain tissue from Parkinson’s disease patients. Glucocerebrosidase is also highly expressed in peripheral blood monocytes where its activity is decreased in Parkinson’s disease patients, even in the absence of GBA mutation. Objective: To measure glucocerebrosidase activity in cryopreserved peripheral blood monocytes from 30 Parkinson’s disease patients and 30 matched controls and identify any clinical correlation with disease severity. Methods: Flow cytometry was used to measure lysosomal glucocerebrosidase activity in total, classical, intermediate, and non-classical monocytes. All participants underwent neurological examination and motor severity was assessed by the Movement Disorders Society Unified Parkinson’s Disease Rating Scale. Results: Glucocerebrosidase activity was significantly reduced in the total and classical monocyte populations from the Parkinson’s disease patients compared to controls. GCase activity in classical monocytes was inversely correlated to motor symptom severity. Conclusion: Significant differences in monocyte glucocerebrosidase activity can be detected in Parkinson’s disease patients using cryopreserved mononuclear cells and monocyte GCase activity correlated with motor features of disease. Being able to use cryopreserved cells will facilitate the larger multi-site trials needed to validate monocyte GCase activity as a Parkinson’s disease biomarker.


Sign in / Sign up

Export Citation Format

Share Document